BrioHealth Solutions key facts
as of Oct 2026- Manufacturer of ventricular assist devices VADs aims to transform heart failure treatment with advanced artificial heart technologies.
- BrioHealth Solutions is valued at approximately $144.7M as of Oct 2026 (last reported valuation).
- It has raised $100.0M; the latest was IPO in Dec 2025.
- Notable investors include HSG (Hong Kong), CICC Capital, Highlight Capital, China Growth Capital, BlackPine Group — 20 tracked in total.
- Status: In IPO Registration.
BrioHealth Solutions's last reported valuation, Jun 2019. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch BrioHealth Solutions: the Monday email on marks, rounds and moves
BrioHealth Solutions funding rounds
No funding rounds for BrioHealth Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs BrioHealth Solutions
20+BrioHealth Solutions valuation
BrioHealth Solutions's last reported valuation was $145 million in Jun 2019. No priced round, secondary trade or fund mark has surfaced since.
BrioHealth Solutions investors
20 investors are on record for BrioHealth Solutions, including HSG (Hong Kong), CICC Capital, Highlight Capital and China Growth Capital.
About BrioHealth Solutions
Manufacturer of ventricular assist devices VADs aims to transform heart failure treatment with advanced artificial heart technologies. The company develops VAD with high reliability, excellent hemocompatibility and a decreased rate of adverse events, helping clinicians and patients benefit from improved blood compatibility, infection control, and device longevity, enabling broader global access to high-end heart failure solutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2008
- Employees
- 86
- Website
- briohealthtech.com/
- Ownership
- In IPO Registration
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.